Diltiazem Hydrochloride Information
What's inside Diltiazem Hydrochloride
Diltiazem Hydrochloride Active Ingredients: diltiazem hydrochloride, details.| Diltiazem Hydrochloride Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Diltiazem Hydrochloride 30 mg | tablet | oral | 1.0 each | OTC |
| Diltiazem Hydrochloride 60 mg | tablet | oral | 1.0 each | OTC |
| Diltiazem Hydrochloride 90 mg | tablet | oral | 1.0 each | OTC |
| Diltiazem Hydrochloride 120 mg | tablet | oral | 1.0 each | OTC |
| Diltiazem Hydrochloride 100 mg | powder for injection | intravenous | 1.0 each | OTC |
| Diltiazem Hydrochloride 5 mg/mL | solution | intravenous | 1.0 milliliter(s) | OTC |
| Diltiazem Hydrochloride - | powder | compounding | 100.0 gram(s) | OTC |
Recent Diltiazem Hydrochloride Side Effects
Posted by bigmamaixix 5 months ago
Swollen ankles, weight gain, tired all the time, peeling skin/rashes, vision worsened, edema, depression, anxiety. All this ...
Posted by gunslinger383 about 1 year ago
NO PROBLEMS
Diltiazem Hydrochloride in the News
FDA starts inspecting stalled Watson facility - In-PharmaTechnologist.com
Also on hold is an approval application for Watson's branded antidiabetic, Actos (pioglitazone hydrochloride) plus MET (metformin) XR. ...
Mon Feb 18 07:01:31 -0500 2008
Elan Reports Fourth Quarter and Full-Year 2007 Financial Results - WELT ONLINE
On June 18, 2007, the first generic formulation of cefepime hydrochloride was approved by the US Food and Drug Administration (FDA). ...
Wed Feb 13 02:16:42 -0500 2008
Elan Reports Fourth Quarter and Full-Year 2007 Financial Results - WELT ONLINE
On June 18, 2007, the first generic formulation of cefepime hydrochloride was approved by the US Food and Drug Administration (FDA). ...
Wed Feb 13 02:16:42 -0500 2008
Diltiazem Hydrochloride Chemical Information
diltiazem hydrochloride - A benzothiazepine calcium channel blocking agent. Diltiazem hydrochloride inhibits the transmembrane influx of extracellular calcium ions into select myocardial and vascular smooth muscle cells, causing dilatation of coronary and systemic arteries and decreasing myocardial contractility. Because of its vasodilatory activity, this agent has been shown to improve the microcirculation in some tumors, thereby potentially improving the delivery of antineoplastic agents to tumor cells. (NCI04)
Diltiazem Hydrochloride RSS Feed